Seres Therapeutics Inc

NASDAQ:MCRB   1:00:00 PM EDT
11.87
+1.01 (+9.30%)
4:52:43 PM EDT: $11.87 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Seres Therapeutics Inc Stock, NASDAQ:MCRB

101 Cambridge Park Drive, 4th floor, Cambridge, Massachusetts 02140
United States of America
Phone: +1.617.945.9626
Number of Employees: 233
http://www.serestherapeutics.com

Description

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.